D
Neurogene Inc. NGNE
$19.98 -$0.01-0.05% NASDAQ
Recommendation
Prev Close
$19.99
Volume
82,355
Avg Vol (90D)
190,799
Market Cap
$285.30M
Dividend & Yield
--
52-Week Range
$6.88 - $74.49
P/E (TTM)
--
EPS (TTM)
-$4.32
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Neurogene Inc. (NASDAQ:NGNE) Given Average Rating of "Moderate Buy" by Brokerages
8/22/2025 - Ticker Report
Neurogene (NGNE, $19.75) Aroon Indicator entered a Downtrend on August 21, 2025.
8/22/2025 - Tickeron - Stocks
Neurogene (NGNE, $19.61) Aroon Indicator entered a Downtrend on August 20, 2025.
8/21/2025 - Tickeron - Stocks
Neurogene (NGNE, $19.61) Stochastic Oscillator left the oversold zone on August 20, 2025
8/21/2025 - Tickeron - Stocks
Neurogene (NGNE, $19.71) price exceeded its 50-day Moving Average on August 19, 2025
8/20/2025 - Tickeron - Stocks
William Blair Issues Negative Outlook for Neurogene Earnings
8/16/2025 - MarketBeat
Neurogene (NGNE, $20.51) price moved above its 50-day Moving Average on August 15, 2025
8/16/2025 - Tickeron - Stocks
Neurogene (NGNE, $20.2) Stochastic Oscillator left the oversold zone on August 14, 2025
8/15/2025 - Tickeron - Technical Analysis
Neurogene (NGNE, $20.2) price exceeded its 50-day Moving Average on August 14, 2025
8/15/2025 - Tickeron - Stocks
Stifel Nicolaus Sticks to Their Buy Rating for Neurogene (NGNE)
8/14/2025 - TipRanks Financial Blog
Neurogene (NGNE, $21.11) RSI Indicator left the oversold zone on August 13, 2025
8/14/2025 - Tickeron - Stocks
Neurogene (NGNE, $21.11) price moved above its 50-day Moving Average on August 13, 2025
8/14/2025 - Tickeron - Stocks
We Think Neurogene (NASDAQ:NGNE) Can Afford To Drive Business Growth
8/13/2025 - Simply Wall St
Neurogene (NGNE, $19.22) RSI Indicator left the oversold zone on August 12, 2025
8/13/2025 - Tickeron - Stocks
Neurogene (NASDAQ:NGNE) Issues Quarterly Earnings Results, Beats Estimates By $0.10 EPS
8/13/2025 - MarketBeat
Neurogene Inc Reports Q2 2025 EPS Miss, Net Loss of $22 Million; Strong Cash Position of $274. ...
8/13/2025 - GuruFocus
Neurogene Reports Second Quarter 2025 Financial Results and Highlights Recent Updates
8/11/2025 - GuruFocus
Neurogene Reports Second Quarter 2025 Financial Results and Highlights Recent Updates NGNE ...
8/11/2025 - GuruFocus
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
8/8/2025 - GuruFocus
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NGNE Stock News
8/8/2025 - GuruFocus
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
8/8/2025 - Business Wire
Neurogene (NGNE, $21.45) Stochastic Oscillator left the oversold zone on August 05, 2025
8/6/2025 - Tickeron - Stocks
Neurogene (NGNE, $21.45) entered Downtrend as Momentum indicator drops below 0 level on Aug 05, 2025
8/6/2025 - Tickeron - Stocks
Neurogene (NGNE, $21.72) entered Uptrend as Momentum indicator ascends above 0 level on Aug 04, 2025
8/5/2025 - Tickeron - Stocks
Neurogene (NGNE, $21.78) Stochastic Oscillator left the oversold zone on August 01, 2025
8/2/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$0.00
EBITDA (TTM)
-$92.56M
EBIT (TTM)
-$95.69M
Net Income (TTM)
-$84.39M
Balance Sheet
Total Assets (Q)
$297.32M
Total Debt (Q)
$10.97M
Total Liabilities (Q)
$24.06M
Book Value Per Share (Q)
$19.15
Cash Flow
Cash from Operations (TTM)
-$73.30M
Cash from Investing (TTM)
-$169.18M
Cash from Financing (TTM)
$190.25M
Net Change in Cash (TTM)
-$52.22M
Filings
Filing Date
Monday, August 11, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 17 and 21 (est)
Price History
Loading...
Beta
--
7-Day Total Return
-1.09%
30-Day Total Return
-10.24%
60-Day Total Return
6.62%
90-Day Total Return
75.88%
Year to Date Total Return
-12.71%
1-Year Total Return
-42.82%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 08, 2025 - $6.88
52-week High
Nov 11, 2024 - $74.49
Valuation
Market Cap
$285.30M - Micro Cap
Enterprise Value
$21.74M
Price/Sales (TTM)
--
Price/Book (Q)
1.04
Dividends and Shares
Shares Outstanding
21.06
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.neurogene.com
Phone Number
855 508 3568
Address
535 W 24th Street
New York, NY 10011
Country
United States
Year Founded
2018
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an... more
NASDAQ 08/25/2025 4:00PM Eastern Quotes delayed